| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.06 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |